CS Paper Radar

Weighted Spline-Expanded Networks with Distributional Balancing for Continuous Treatment Effects

Shucheng Liu, Chan Park, Guanhua Chen

cs.LG stat.ML ·submitted 2026-09-27 16:41 UTC · v1

Abstract

Estimating causal effects with continuous treatments in observational studies is challenging due to confounding, model misspecification, and high-dimensional covariates. We propose the Weighted Spline-Expanded Network (WSENet), an end-to-end neural framework that addresses these challenges by combining covariate balancing, structured treatment embedding, and bias-corrected outcome estimation. WSENet first applies Distance Covariate Optimal Weights to induce distributional independence between covariates and treatment without relying on parametric models. It then learns the conditional outcome via a structured network that fuses outcome-relevant representations of covariates with a spline-expanded treatment input, enabling smooth and flexible modeling of the dose-response relationship. To mitigate residual bias, we introduce Weighted Targeted Regularization, a correction technique based on efficient influence functions that yields a doubly robust estimator. Extensive evaluations on semi-synthetic and real-world datasets, including high-dimensional genomic and environmental health data, demonstrate that WSENet consistently outperforms existing baselines in both accuracy and stability.

Closest papers

Nearest neighbours by meaning across the whole index.

Proximal Causal Learning under Unmeasured Confounding

cs.LG ·2026-10-03 ·Ying Tang, Yi Wang
similarity 0.70
Abstract · 14 pages,4 figures

Estimating treatment effects from observational data typically relies on the No Unmeasured Confounding Assumption (NUCA), which rarely holds in practice. Proximal causal learning (PCL) addresses unmeasured confounding via proxy variables, yet existing methods require the proxy variables to be pre-specified. Thus, we propose PCL-U, a framework that learns proxy variables directly from observed covariates. PCL-U uses neural encoders to decompose covariates into treatment-inducing, outcome-inducing, and shared proxies, guided by minimax mutual information objectives, and obtains causal estimates through a practical moment-based risk function. Experiments on benchmarks show that PCL-U matches or outperforms existing baselines. Besides, there are two types of synthetic datasets with varying dimensions and confounding strengths that illustrate that our method maintains stable estimation accuracy.

0.14

Barycentric Fused Gromov-Wasserstein Balancing for Causal Inference under Multiple Treatments

cs.AI stat.MEcs.LGstat.ML ·2026-08-22 ·Yuki Murakami, Takumi Hattori, Kohsuke Kubota
similarity 0.66
Abstract · 26 pages

Estimating heterogeneous single and interaction treatment effects from observational data under multiple simultaneous treatments is crucial for decision-making. To mitigate estimation variance, previous studies balance representation distributions between every pair of treatment patterns. However, such pairwise balancing scales quadratically with the number of treatment patterns and fails to preserve consistent local proximity structures across patterns, which degrades counterfactual estimation. To address these challenges, we propose the Causal Inference for Heterogeneous Single and Interaction Treatment Effects Network (CIHSI-Net), a deep learning framework built on a novel Barycentric Fused Gromov-Wasserstein Balancing (BFG-WB) objective. BFG-WB aligns the representation distribution of each treatment pattern with a shared Wasserstein barycenter, achieving global alignment while reducing the computational complexity from quadratic to linear, and its Fused Gromov-Wasserstein discrepancy preserves the local proximity structures essential for reliable heterogeneous effect estimation. Simulation studies show that CIHSI-Net consistently outperforms state-of-the-art baselines, and an application to real-world marketing data demonstrates its practical utility in complex multi-treatment scenarios.

0.30

SIRNET: Causal Adaptation of Pretrained Embeddings for Semiparametric Treatment-Effect Estimation Under Surrogacy

cs.LG stat.ME ·2026-09-29 ·Lei Shi, Qiuran Lyu
similarity 0.66
Abstract

Modern experiments increasingly produce rich post-treatment objects---such as text, images, and video---that may provide early surrogate signals for outcomes that are delayed, expensive, or observed only for a subset of participants. A pretrained encoder can turn such an object into a strong generic embedding, but the embedding is not trained for the estimation tasks required by a causal estimator and may emphasize information irrelevant to the causal target. We propose SIRNET, a Surrogate-Informed Representation adaptation framework for neural-NETwork-based causal estimation in the presence of unstructured post-treatment surrogates. Starting from pretrained surrogate embeddings, SIRNET learns a shared adapter jointly for outcome prediction, treatment propensity, and arm-specific surrogate marginalization, beyond the generic pretraining objective. The resulting covariate and surrogate representations provide a common interface for these nuisance tasks. The final treatment-effect estimate and confidence interval are obtained from cross-fitted orthogonal scores that attain the semiparametric efficiency bound under the stated nuisance-rate conditions. We also validate SIRNET's performance in synthetic and semisynthetic experiments, as well as the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) trial, using frozen pretrained brain-MRI embeddings as surrogates for a long-term outcome.

0.26

Causal Foundation Models

cs.LG stat.ML ·2026-09-02 ·Christopher Stith, Hossein Rahmani, Jesse C. Cresswell
code/data similarity 0.65
Abstract · Code is available at https://github.com/layer6ai-labs/cfms

Causal inference is the practice of estimating the effect of a treatment or intervention from data. It traditionally requires a bespoke pipeline for every new problem: first proposing a causal mechanism, selecting a compatible estimator, and finally training it. Meanwhile, across diverse settings and modalities, much of machine learning has shifted to the paradigm of foundation models: networks pretrained once at scale and applied to new tasks without fine-tuning. Causal foundation models (CFMs) bring this paradigm to causal inference. CFMs are pretrained neural networks that estimate causal quantities, such as the average treatment effect, on entirely new datasets using in-context learning without requiring model updates. This work provides a practical introduction to this emerging area. We summarize the necessary background in causal inference and machine learning before discussing CFMs. Throughout, we include example code and Jupyter notebooks.

0.47

A Foundation Model for Policy In-Context Longitudinal Causal Effect Estimation

cs.AI ·2026-10-23 ·Wenxin Chen, Kyra Gan, Mingyu Lu, Zilin Jing, Fei Wang +3 more
similarity 0.65
Abstract

Longitudinal causal effect estimation is complicated by time-varying confounding and treatment-confounder feedback loops. Existing methods generally require data-specific nuisance-model fitting, and many are tailored to prespecified treatment sequences or prediction horizons, leading to time-consuming computation at deployment. We introduce *Policy In-Context Longitudinal causal Effect estimation with Prior-data Fitted Networks* (**PICLE-PFN**), the first foundation model for longitudinal causal effect estimation that supports *dynamic* treatment policies. PICLE-PFN represents target policies through in-context history-decision demonstrations, providing a unified interface for a broad class of treatment policies. Pretrained over synthetic data sampled from longitudinal structural causal models, PICLE-PFN amortizes causal effect estimation across datasets, policies, and horizons. Given a new observational dataset and target policy, it directly predicts conditional average potential outcomes (CAPOs) in one forward pass without task-specific training or hyperparameter tuning. Across synthetic and semi-synthetic longitudinal benchmarks, PICLE-PFN achieves competitive RMSE and substantially improved uncertainty calibration with a fraction of deployment runtime, compared to state-of-the-art conventional estimators trained and tuned separately for each dataset.

0.13

Proximal Balancing for Causal Effect Estimation under Unmeasured Confounding

cs.LG stat.MLstat.ME ·2026-09-30 ·Yonghan Jung
code/data similarity 0.64
Abstract · 59 pages. Code: https://github.com/CausalDataScience/proximal-balancing

Estimating causal effects from observational data is central to science and policy, but the effects are not identified when confounders are unmeasured. Proximal causal inference addresses this problem with proxies of the unmeasured confounders. However, existing proxy-based approaches either designate proxy roles and solve an inverse problem, which is ill-posed and hard to estimate with high-dimensional proxies, or use a latent-variable model, which assumes that the learned latent variable matches the hidden confounder and leaves bias when it does not. To address these challenges, we introduce proximal balancing. It carries the classical idea of covariate balancing to confounders that are observed only through proxies: it learns a low-dimensional summary of the covariates and proxies that makes the treatment groups comparable, and then adjusts for this summary. It needs no designated proxy roles, inverse problem, or latent model. We give identification theory, finite-sample guarantees, and a practical algorithm, PROBE. We demonstrate the method on low-dimensional, high-dimensional, and image proxies and on real-world data.

0.33

Representation Learning for Sample-Efficient CATE Estimation by Leveraging Multiple Outcomes

cs.LG ·2026-09-05 ·Maitreyi Swaroop, Shikha Bhat, Samantha Rodriguez, Tamar Krishnamurti, Bryan Wilder
theory similarity 0.64
Abstract

Estimating conditional average treatment effects (CATE) enables efficient targeting of interventions, but many applications have limited experimental samples, making it difficult to estimate heterogeneous effects from high-dimensional covariates. In such settings, policymakers and medical practitioners often succumb to the curse of dimensionality or apply off-the-shelf dimension reduction methods that may not preserve treatment heterogeneity. Yet these domains often come with large historical datasets measuring a wide range of outcomes -- a source of supervision that is rarely exploited in practice. Following causal representation learning, we hypothesize that such domains with high-dimensional covariates have lower-dimensional underlying dynamics. We can thus leverage the diverse outcomes measured in historical data to learn a lower-dimensional representation of the covariates. Theoretically, we prove that when the auxiliary outcomes satisfy a set of surrogacy conditions and the representation retains relevant covariate information, the original CATE is identified when the high-dimensional covariates are replaced by the learned representation. Combined with existing dimension-dependent rates for CATE estimation, the result implies greater sample-efficiency on the same experimental sample. Additionally, we characterize the bias-variance tradeoff when the assumptions do not hold perfectly, and show that the representation-based estimator can still achieve lower error when the reduction in estimator variance outweighs the bias due to compression. Empirically, we evaluate the method on synthetic data and semi-synthetic medical data.

0.21

Artificial intelligence surrogates for treatment effect estimation with before-and-after data

cs.LG stat.ML ·2026-09-23 ·Frances Dean, Anna Neufeld, Joshua Barrios, Geoffrey H Tison, Ahmed Alaa
similarity 0.64
Abstract

Estimating the causal effects of medical treatments is difficult when clinically important outcomes are costly to measure or require long follow-up. Short-term or inexpensive surrogate outcomes offer a potential alternative, but surrogate biomarkers may be unavailable or difficult to identify. Advances in artificial intelligence (AI) have enabled increasingly accurate prediction of clinical outcomes from inexpensive, high-dimensional measurements, which creates an opportunity to use AI predictions themselves as surrogates. To this end, we develop a framework for estimating treatment effects from paired measurements obtained before and after treatment for each treated individual. A pretrained AI model is applied to the before and after measurements, and our estimator compares the resulting outcome predictions. We characterize the technical assumptions under which this within-person contrast identifies the average treatment effect on the treated, even when clinical outcomes are never observed for treated individuals. When these assumptions cannot be justified, we use prediction-powered inference to correct bias using a small number of observed clinical outcomes and obtain valid inference. Synthetic and real-world cardio-oncology experiments demonstrate the validity and accuracy of the approach.

0.17